Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Optimizing Amyloid Biomarker Use to Guide Antiamyloid Immunotherapy Eligibility in Alzheimer Disease: Suzanne Schindler, MD, PhD
2
NeuroVoices: Jeff Dage, PhD, on Clinical Implementation of Blood-Based Biomarkers in Alzheimer Disease
3
FDA Accepts NDA for Axsome Therapeutics’ AXS-12 for the Treatment of Cataplexy in Narcolepsy
4
Baseline Tau Burden Linked to Reduced Amyloid Clearance With Gantenerumab in New GRADUATE Analysis
5